162 results on '"Kindler, H"'
Search Results
2. 1298P Extended overall survival results from the POLO study of active maintenance olaparib in patients with metastatic pancreatic cancer and a germline BRCA mutation
3. Frühe Hilfen und interventiver Kinderschutz – eine Abgrenzung
4. DREAM3R: DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma: A Phase 3 Randomised Trial
5. FP07.05 DREAM3R: Durvalumab With Chemotherapy as First Line Treatment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial
6. OA12.01 Genomic and Immune Cell Landscape of Response to Chemo-Immunotherapy in Malignant Pleural Mesothelioma
7. 1467P POLO: Long-term safety and tolerability of olaparib for patients with a germline BRCA mutation and metastatic pancreatic cancer
8. 1468P POLO: Subsequent therapy after maintenance olaparib in patients with a germline BRCA mutation and metastatic pancreatic cancer
9. P-105 POLO: Patient-centred outcomes with maintenance olaparib in patients with a germline BRCA mutation and metastatic pancreatic cancer
10. Toxicity and Efficacy of Stereotactic Body Radiotherapy plus Nivolumab with Urelumab or Cabiralizumab in Patients with Advanced Solid Tumors
11. Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients
12. 1527P Assessing clinical benefit of olaparib maintenance treatment in subgroups of patients with germline BRCA mutation (gBRCAm) and metastatic pancreatic cancer: Phase III POLO trial
13. SO-3 Maintenance olaparib in patients aged ≥65 years with a germline BRCA mutation and metastatic pancreatic cancer: phase III POLO trial
14. SO-4 phase Ib/II, open-label, randomised evaluation of atezolizumab plus RO6874281 vs control in MORPHEUS–pancreatic ductal adenocarcinoma
15. Colorectal Cancer
16. Mesothelioma
17. Mesothelioma
18. Mapping laboratory medicine onto the select and test model to facilitate knowledge-based report generation in laboratory medicine
19. P1.06-04 Deep Learning-Based Segmentation of Mesothelioma on CT Scans: Application to Patient Scans Exhibiting Pleural Effusion
20. P2.06-12 Dysphagia in Patients with Malignant Pleural Mesothelioma (MPM)
21. Olaparib as maintenance treatment following first-line platinum-based chemotherapy in patients with a germline BRCA mutation and metastatic pancreatic cancer: phase III POLO trial
22. Wissensbasierte Unterstützung bei der Behandlung des akuten Strahlensyndroms
23. Modell zur Simulierung der pulmonalen Eliminierung von Benzol bei der Maus nach intraperitonealer Bolusgabe
24. RADES — Medical Assistance System for the Management of Irradiated Persons
25. Better Justifiability and Less Rules by Using Deep Knowledge
26. A Phase I/II Trial of Stereotactic Body Radiation Therapy for Unresectable Pancreatic Cancer Using Ablative (BED100) Doses
27. A genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients
28. Countering posttraumatic LHPA activation in refugee mothers and their infants
29. Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance)
30. A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors
31. The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma
32. The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma
33. 208O_PR: CRS-207 with chemotherapy (chemo) in malignant pleural mesothelioma (MPM): Results from a phase 1b trial
34. 87 Mesothelin-targeted immunotherapy CRS-207 plus chemotherapy as treatment for malignant pleural mesothelioma (MPM)
35. P-265TUMOUR VOLUME: AN IMPORTANT PREDICTOR OF SURVIVAL IN MALIGNANT PLEURAL MESOTHELIOMA
36. SU-F-207-06: CT-Based Assessment of Tumor Volume in Malignant Pleural Mesothelioma
37. Experimentelle Ergebnisse bei homologer (Schwein-Schwein) extrakorporaler Leberperfusion
38. Die Behandlung des Leberkomas mit Hilfe der heterologen Leberperfusion
39. An advisor for the management of the acute radiation syndrome
40. Dynamik des Zelleiwei�stoffwechsels im Granulationsgewebe
41. Multi-Arm, Nonrandomized, Open-Label Phase Ib Study to Evaluate Fp1039/Gsk3052230 with Chemotherapy in Nsclc and Mpm with Deregulated Fgf Pathway Signaling
42. Child Abuse and Neglect: Screening for Risks During the Perinatal Period
43. VANTAGE 014: Vorinostat (V) in Patients With Advanced Malignant Pleural Mesothelioma (MPM) who Have Failed Prior Pemetrexed and Either Cisplatin or Carboplatin Therapy: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial
44. 6604 POSTER Updated Survival and Genomic Analysis of a Phase II Trial of Temsirolimus in Advanced Neuroendocrine Carcinomas
45. 6588 POSTER Phase 3 Dose Selection for Ganitumab (AMG 479) in Pancreatic Cancer Based on Clinical Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Assessments
46. SU‐E‐J‐93: Perfusion CT and Tumor Response for Patients with Mesothelioma
47. SU‐E‐J‐96: Prognostic Value of Automatically Segmented Lung Volumes during Chemotherapy for Patients with Mesothelioma
48. Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: Results from CALGB 80303.
49. Exposure-response (E-R) analysis to facilitate phase III (P3) dose selection for ganitumab (GAN, AMG 479) in combination with gemcitabine (G) to treat metastatic pancreatic cancer (mPC).
50. Sorafenib (SOR) in patients (pts) with imatinib (IM) and sunitinib (SU)-resistant (RES) gastrointestinal stromal tumors (GIST): Final results of a University of Chicago Phase II Consortium trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.